Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 50090-4872

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 50090-4872). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500904872)

Packaging label for Valsartan and Hydrochlorothiazide 160 mg/25 mg film-coated tablets by A-S Medication Solutions. The label indicates a 90-tablet bottle, instructs storage at 77 degrees Fahrenheit and protection from moisture, and includes the product NDC 50090-4872-0 with lot and expiration date details.*

FDA Label Image

Figure 1 (Valsahctz Figur1)

A line graph showing the probability of achieving systolic blood pressure under 140 mmHg at week 8, plotted against baseline systolic blood pressure (SBP) values ranging from 140 to 180 mmHg. Four distinct curves represent Valsartan and hydrochlorothiazide tablets 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo, with Valsartan and hydrochlorothiazide tablets showing the highest probability across baseline SBP values.*

FDA Label Image

Figure 2-3-4 (Valsahctz Figure2 3 4)

Three line graphs showing probability of achieving specific blood pressure goals at Week 8 for Valsartan and Hydrochlorothiazide 320/25 mg tablets, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo. Graphs depict percentage achieving diastolic blood pressure <90 mmHg vs baseline DBP, systolic blood pressure <130 mmHg vs baseline SBP, and diastolic blood pressure <80 mmHg vs baseline DBP.*

FDA Label Image

Structure (Valsahctz Hctz)

Chemical structure of Valsartan and Hydrochlorothiazide showing molecular connectivity including sulfonamide, chlorine, and other functional groups in the molecule.*

FDA Label Image

Structure (Valsahctz Valsa)

Chemical structure diagram of the active ingredient Valsartan, showing its molecular composition with typical bond and ring structures as depicted in pharmaceutical labeling.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.